CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
Attend An Event
State of the Science Summit
Regional Seminar Series
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
<< View More Conferences
2017 Lynn Sage Breast Cancer Symposium
Oncology Conference Multimedia
View more videos >>
Dr. Cristofanilli on Endocrine Therapy for Breast Cancer
Dr. Hurria on Challenges Facing the Geriatric Population with Breast Cancer
Dr. Muss on Adjuvant Therapy for Elder Patients with Breast Cancer
Oncology Conference Articles
Biomarkers Needed for Premenopausal Women With Breast Cancer
Ongoing studies are hoping to find a biomarker to guide which premenopausal women with ER-positive breast cancer need extended adjuvant therapy and which need ovarian function suppression.
Older Breast Cancer Patients Require Special Consideration
Treating older patients with breast cancer must include more quality of life considerations and different types of survival calculations.
Stage, ER Status Guide HER2 Therapy Selection in Breast Cancer
The sequencing of therapies for patients with HER2-positive breast cancer is largely driven by stage of disease and hormone receptor status.
Implementation Research Key to Solving Global Cancer Care Puzzle
Health investment is failing to match the challenge presented by a growing cancer burden in countries at all economic levels, enhancing the need for new approaches that help optimize the delivery of care.
Precision Medicine Moving Beyond HER2 in Breast Cancer
There is a significant transformation underway in the treatment of breast cancer as research advances and new laboratory techniques continue to shrink the so-called "undruggable genome."
Ovarian Suppression Individualization Warranted in Breast Cancer
Patients have a hard time with artificially induced menopause and some research suggests it may have a negligible effect on the success of their treatment.
Multigene Testing Adds Complexity to Decision Making Process
Multigene panel testing offers a new but often puzzling tool for breast cancer treatment, since the results are often difficult to interpret, both for relative risk and risk management.
IBM's Watson has Potential Partnership With Oncologists
Even with advancements in technology, the prospect of artificial intelligence treating patients with cancer still remains out of reach. At least, for now.
"Opioid Epidemic" Increases Challenge of Treating Cancer Pain
Extra vigilance, careful management, and an emphasis on empathy makes treating cancer pain more effective during an opioid addiction epidemic.
FDA Approval in HCC, Breakthrough Designation in MCL, and More
Dabrafenib/Trametinib Combo Induces High Responses in BRAF V600E-Mutant Biliary Tract Cancer
Treatment Goals in Refractory mCRC
FDA Approves Third Trastuzumab Biosimilar
Olaratumab Falls Short in Phase III Soft Tissue Sarcoma Trial
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.